Lior Raviv
Technik-/Wissenschafts-/F&E-Leiter bei PLURI INC.
Aktive Positionen von Lior Raviv
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PLURI INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Geschäftsführer | 01.01.2011 | - |
Karriereverlauf von Lior Raviv
Ehemalige bekannte Positionen von Lior Raviv
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.07.2010 | 01.02.2011 |
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Geschäftsführer | - | - |
Ausbildung von Lior Raviv
Ben-Gurion University of the Negev | Undergraduate Degree |
Statistik
International
Israel | 5 |
Operativ
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PLURI INC. | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Commercial Services |
- Börse
- Insiders
- Lior Raviv
- Erfahrung